Topical Zhiyang Pingfu Liquid for Moderate to Severe Skin Rash Associated With EGFRIs: A double-blinded randomized controlled trial

BACKGROUND: Skin rash is the most common adverse effect associated with epidermal growth factor receptor inhibitors (EGFRIs). The study has observed the efficacy and safety of Zhiyang Pingfu Liquid in the treatment of EGFRIs-related moderate and severe rash. METHODS: Patients suffering from EGFRIs-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingyi, Lu, Xingyu, Zhang, Xu, Tan, Kexin, Li, Jia, Cui, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703570/
https://www.ncbi.nlm.nih.gov/pubmed/36419383
http://dx.doi.org/10.1177/15347354221140409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703570/
https://www.ncbi.nlm.nih.gov/pubmed/36419383
http://dx.doi.org/10.1177/15347354221140409

Ejemplares similares